---
title: "600812.SH (600812.SH) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/600812.SH/news.md"
symbol: "600812.SH"
name: "600812.SH"
parent: "https://longbridge.com/en/quote/600812.SH.md"
datetime: "2026-05-21T22:32:34.843Z"
locales:
  - [en](https://longbridge.com/en/quote/600812.SH/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/600812.SH/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/600812.SH/news.md)
---

# 600812.SH (600812.SH) — Related News

### [NCPC: Net profit in the first quarter was 35.4728 million yuan, a year-on-year decrease of 38.30%](https://longbridge.com/en/news/283980120.md)
*2026-04-24T10:14:03.000Z*
> NCPC announced that in the first quarter of 2026, it achieved operating revenue of 2.153 billion yuan, a year-on-year de

### [NCPC: Obtained the drug registration certificate for Letermovir injection](https://longbridge.com/en/news/283320897.md)
*2026-04-20T08:51:50.000Z*
> NCPC recently obtained the drug registration certificate for Letermovir Injection approved by the National Medical Produ

### [NCPC: Net profit of 183 million yuan in 2025, a year-on-year increase of 44.15%](https://longbridge.com/en/news/283143318.md)
*2026-04-17T12:22:18.000Z*
> NCPC announced that the operating revenue for 2025 is expected to be 9.242 billion yuan, a year-on-year decrease of 6.36

### [Taiwan Stock Market Update: PharmaEngine and Unimicron Reach New Highs, AI Job Openings Surge, Logistics Challenges Coexist with Wind Power Growth](https://longbridge.com/en/news/281827693.md)
*2026-04-07T04:20:06.000Z*
> The Taiwan stock market dynamics show that PharmaEssentia and Unimicron have reached historical highs, with a surge in A

### [Revenue Flash - YaoHua Pharmaceutical (6446) March revenue reached NT$ 1.94 billion, with a year-on-year growth rate of 64.35%](https://longbridge.com/en/news/281721986.md)
*2026-04-06T00:15:22.000Z*
> YaoHua Pharmaceutical (6446-TW) announced that its revenue for March 2026 was NT$ 1.94 billion, a year-on-year increase 

### [99% of revenue relies on a single medicine! Used by everyone from infants to the elderly, but the exclusive protection period is less than five years remaining, Hanfang Pharmaceutical urgently seeks a "second leg"](https://longbridge.com/en/news/278098733.md)
*2026-03-06T09:58:12.000Z*
> Shandong Hanfang Pharmaceutical's "Compound Huangbai Liquid Ointment" is its core product, with annual sales nearing 1 b

### [Four companies collectively accepted hearings, and the regulation of the entire chain in the pharmaceutical field is gaining momentum again](https://longbridge.com/en/news/277021631.md)
*2026-02-26T10:09:12.000Z*
> The State Administration for Market Regulation will hold hearings on February 28 for four pharmaceutical companies, incl

### [The new policies in the Taiwan stock market promote the recovery of pharmaceutical and machine tool industries, while the electronic market demonstrates corporate resilience amid challenges](https://longbridge.com/en/news/276490729.md)
*2026-02-20T22:00:04.000Z*
> The new policies in Taiwan are driving the recovery of pharmaceutical and machine tool industries, while the electronics

### [Taiwan Stock Market Outlook: Pharmaceutical companies benefit from trade agreements, laptop manufacturers transform to survive, and Jingpeng's performance is expected to improve](https://longbridge.com/en/news/276441306.md)
*2026-02-20T12:20:04.000Z*
> The outlook for the Taiwan stock market indicates that pharmaceutical companies such as YaoHua Pharmaceutical, BaoRui, a